Presentation Title

Egypt Genome; From Dream to Reality

Abstract

Background: Studying the human genome is crucial to embrace precision medicine through tailoring treatment and prevention strategies to the unique genetic makeup and molecular information of individuals. After human genome project (1990–2003) generated the first full sequence of a human genome, there have been concerns towards Northern bias due to underrepresentation of other populations. Multiple countries have now established national genome projects aiming at the genomic knowledge that can be harnessed from their populations. Key scientific concepts: EG generated genomic knowledge is predicted to enrich the existing human genome and to expand its diversity by studying the underrepresented African/Middle Eastern populations. The insightful impact of EG is to fill the knowledge gaps in health and disease genomics towards improved and sustainable genomic-driven healthcare systems for better outcomes. Promoting the integration of genomics into clinical practice and spearheading the implementation of genomic-driven healthcare and precision medicine is therefore a key focus of EG. Mining into the wealth of Ancient Egyptian Genomics to delineate the genetic bridge between the contemporary and Ancient Egyptian populations is another excitingly unique area of EG to realize the global vision of human genome. Aim of review & Update: The intention is to introduce the recently established Egypt Genome (EG) to delineate the genomics and genetics of both the modern and Ancient Egyptian populations. Leveraging genomic medicine to improve precision medicine strategies while building a solid foundation for large-scale genomic research capacity is the fundamental focus of EG. The update describes the milestones the project passed through and the challenges faced.

Biography

Prof. Khaled Amer is a Professor of Hepatobiliary Surgery, Liver Transplantation, and General Surgery, and a leading authority in medical education, clinical practice, and biomedical research in Egypt. He is the founding Dean of the Armed Forces College of Medicine, where he led the establishment of the institution and the development of its medical curricula in alignment with international standards. In 2018, Prof. Amer was commissioned to establish the Center of Excellence for Research in Regenerative Medicine, which houses the National Reference Genome Laboratory, and he currently serves as the Principal Investigator of the Egyptian Genome Project—one of the country’s flagship initiatives in precision and genomic medicine. With decades of experience in advanced liver and transplant surgery, Prof. Amer maintains a strong academic profile, with regular publications in high-impact, peer-reviewed international journals. He serves on several national scientific and transplant committees and boards, and his contributions to medicine, research, and higher education have been recognized through multiple national honors and awards.

Presentation Title

Karstology (Science of Unlimited Multi-Discipline Approaches), Promising Setting for Industrial Raw Materials

Abstract

This topic sheds light on the importance of the karst phenomenon and its associated economic minerals and ores, as a source of sustainable developmental and industrial needs. What encourages raising this topic is the spread of surface and subsurface karst features and their associated deposits in the Egyptian deserts. Karst is an internationally generic term, originally from the Slavic word “kras” or “krs”, expresses a distinct type of landscape shaped by the dissolution of soluble bedrock most commonly limestone, dolomite, or gypsum by acidic water. In the temperate and tropical areas, where carbonate rocks are exposed, environmental water may combine with CO2 in the atmosphere or in the vegetation cover above the rock to produce a weak solution of carbonic acid (H2CO3) that slowly dissolves the carbonate rocks. The karst topography is characterized by sinkholes (depressions), sinking streams, springs, and sinking, polished rocky outcrops and subsurface features including extensive cave systems, vertical shafts, and underground rivers. Mechanical, chemical, biogenic and residual (red soil, Terra Rosa) sediments often result from the karst processes and covers and/or fills various karst features. Karstology is a comprehensive, multidisciplinary approach that scientifically studies the karst phenomenon and its various surface and subsurface deposits, including their processes of formation, soilification, fossil content, associated economic minerals and ores, the ecology of the karst ecosystems and their biodiversity and karst environments. karst areas have long been recognized as a good trap of certain secondary natural resources. The karst processes cause the concentration of raw materials, minerals, and economic elements, through chemical weathering, dissolution, and infilling of features like caves, sinkholes (dolines), and collapse breccias, the most important of which are karst bauxite (Al, Ga), residual iron/manganese, zinc-lead, copper and barite. Enrichment of REE, V, Nb, and Ti, Cr, Ni, Cd, U and Mo, is commonly verified in karst soils. Although the Egyptian desert is known as a part of one of the world's most arid regions; it actually experienced paleo-humid and paleo-rainy climate for extended periods in ancient geological periods. This can be inferred from the prevalence of karst features and deposits in the limestone rocks that cover approximately 54% of the Egyptian land. Two essential paleo-karst types are recognized and recorded. The first type is represented by fossilized or drowned paleo-karst surfaces demarcating sequence boundaries or unconformities during periods of relatively long-lived exposure and sea level fall as well as intensive paleo-karstification inducing lateritization and pedogenesis along paleo-highs of regional or local scales. The second type is represented by surface paleo- karst features demarcating the present day exposed carbonate sequences. All these karst surfaces are accompanied by karst deposits of varying composition and properties. Such karst sediments necessarily require great attention as they are an important target for the accumulation of minerals and economic elements, which has not yet received sufficient attention in specialized systematic research and studies. Therefore, all disciplines within the basic sciences are invited to participate in studying this phenomenon and its outcomes or sediments. This will reveal more about the unknown aspects of this phenomenon, particularly the economic evaluation of karst deposits, minerals, and elements, including trace and rare elements, consequently could greatly help in supporting the national economy and providing the raw materials needed for traditional and modern industries.

Biography

Prof. Dr. Mortada Mourad Taha El Aref is a pioneering scientific figure and one of the pillars of geology and mineral resource sciences in Egypt and the Arab world. He has dedicated more than fifty years of his life to scientific research and field application, adopting the "ascending scientific induction" methodology that brought about a fundamental transformation in understanding mineral ores and their geological evolution. His impact extended beyond the academic sphere to leave a national imprint through his leadership of the National Metallogenic Map of Egypt Project, iron exploration projects in Aswan and the Bahariya Oases, and his strategic role in international environmental management through leading the Regional Center for the Basel Convention. As the first pioneer of "Karstology" in the region, Dr. El Aref succeeded in decoding the fascinating natural landscapes of the Western Desert and Farafra Protectorates, thereby establishing a knowledge base that links ancient climate history with contemporary environmental tourism. His name remains synonymous with scientific achievement that serves sustainable development and preserves natural heritage for future generations.

Presentation Title

Center of Excellence in Recombinant Biopharmaceutical Proteins (CERBioP) in TBRI; From Scientific Innovation to The Egyptian Biopharmaceutical Industry

Abstract

Concerning the recombinant biopharmaceutical drugs industry, Egypt is the most promising large market in Africa and Middle East. Egypt has strong rising biopharmaceutical industry with massive needs to world class R&D centers in this advanced field. The Center of Excellence in Recombinant Biopharmaceutical Proteins (CERBioP) in Theodor Bilharz Research Institute (TBRI) is a multidisciplinary, world-class level, internationally competitive R&D center and knowledge hub with state-of-the-art scientific capacities in the development and molecular characterization of biologics/biosimilars using advanced ultrahigh resolution mass spectrometry and other deep technologies. The establishment of CERBioP was funded through STDF (project 31257). The center has three integrated platforms, clone development platform, process development platform and bioanalytical platform. CERBioP was established to empower, support and serve the rising Egyptian biopharmaceutical industry through development of production know-how and introduction of services and solutions for discovery, development, production and characterization of recombinant biopharmaceutical proteins and to empower and augment the national applied academic research in this field. Here, we describe our journey from academic R&D and scientific innovations to collaboration with the Egyptian biopharmaceutical industry.

Biography

Professor and head of Biochemistry and Molecular Biology Department and head of Centre of Excellence in Recombinant Biopharmaceutical proteins (STDF Project), Theodor Bilharz Research Institute. Member in the Executive Committee for the National Strategy for Biotechnology and Genetic Engineering Programs. Previous board member of the Genetic Engineering and Biotechnology Institute, Sadat City. STDF reviewer, TBRI reviewer and Elsevier reviewer.

Presentation Title

Science at the Core of Innovation: Reimagining the University–Industry Nexus for Transformative Impact

Abstract

In an era shaped by rapid scientific advancement, technological disruption, and complex global challenges, science has moved beyond the boundaries of laboratories and academic publications to become the central engine of innovation, economic transformation, and sustainable development. Universities today are called upon not only to generate knowledge, but to actively translate scientific discovery into societal value. Positioning science at the core of innovation requires a fundamental rethinking of the relationship between universities and industry—from fragmented interaction to strategic, impact-driven partnership. This keynote presents an integrated vision grounded in long academic and intellectual engagement with higher education reform, innovation systems, knowledge economy, and sustainability. It argues that the modern university must evolve into a dynamic innovation ecosystem—one that connects research, education, and real-world challenges to produce transformative outcomes. Universities that succeed in the twenty-first century will be those capable of converting scientific knowledge into technological solutions, economic competitiveness, and social progress. Central to this transformation is a shift in university–industry relations from traditional collaboration toward co-creation and shared innovation. Effective partnerships are not transactional arrangements, but trust-based, long-term engagements built on mutual benefit, knowledge exchange, and joint responsibility for solving complex problems. By strengthening technology transfer, fostering interdisciplinary research, and building integrated innovation platforms, universities and industry together can generate new pathways for growth and resilience—particularly within emerging and developing knowledge systems. The keynote further highlights the growing convergence between science, sustainability, and the circular knowledge economy. Science-driven innovation is essential for enabling resource efficiency, environmental responsibility, and sustainable industrial transformation. When universities and industry collaborate within a shared framework of innovation and sustainability, they become powerful agents of long-term economic and societal renewal. The keynote concludes with a forward-looking message: nations do not advance by resources alone, but by science when transformed into innovation, and by universities when they become architects of the future. Building effective university–industry partnerships is therefore not only an economic necessity, but a strategic and civilizational imperative for shaping sustainable, knowledge-driven societies.

Biography

Prof. Hamed A. Ead is a distinguished scholar whose career spans chemistry, history and philosophy of science, and cultural diplomacy. He began his academic journey as a research chemist, dedicating nearly three decades to teaching and publishing at Cairo University while actively engaging in international scientific communities. Driven by a broader intellectual vision, he later expanded into the history and philosophy of science, contributing to the understanding of scientific heritage and its societal impact. He played a key role in establishing the Center for Scientific Heritage at Cairo University and subsequently led the Scientific Centers Sector at Egypt’s National Library, strengthening the country’s cultural and scientific infrastructure. Prof. Ead also served internationally as Cultural Counselor in Morocco and as an expert with ISESCO, promoting scientific and cultural collaboration. He currently serves as a member of the Supreme Council of Culture in Egypt, continuing to bridge science, culture, and public engagement.

Presentation Title

Clinical application of adipose derived stem cells in plastic surgery

Abstract

Adipose-derived stem cells (ADSCs) have emerged as a transformative tool in regenerative and reconstructive plastic surgery, offering promising outcomes in tissue repair, soft tissue augmentation, and wound healing. This presentation provides a comprehensive overview of the clinical applications of ADSCs, including their harvesting, isolation, and integration into autologous fat grafting procedures. Emphasis will be placed on the regenerative potential of ADSCs in enhancing graft survival, accelerating wound closure, and improving aesthetic outcomes in reconstructive and cosmetic interventions. Clinical case studies will illustrate practical techniques, patient selection criteria, and outcome assessment, highlighting both the efficacy and safety of ADSC-based therapies. Future perspectives on integrating ADSCs with bioengineered scaffolds, growth factors, and minimally invasive delivery methods will be discussed, underlining their potential to redefine standards in modern plastic and reconstructive surgery.

Biography

Prof. Fathy Khodair is a distinguished Egyptian medical professional who served as the Dean of the Kasr El Aini (Qasr Al-Aini) School of Medicine at Cairo University, one of the most prestigious medical institutions in Egypt and the Middle East. A Consultant in Plastic and Reconstructive Surgery by specialty, his tenure as Dean, primarily during the 2015-2018 period, was marked by a strong focus on infrastructure development, policy implementation, and international collaboration, all aimed at modernizing the historic institution. During his time as Dean, Prof. Khodair oversaw several significant projects that expanded the hospital's capacity to treat critical conditions. In 2016, he announced the inauguration of the Middle East's largest stroke unit within Kasr El Aini. The unit featured 35 beds, including 12 for intensive care, and was designed to provide free, specialized treatment to a large number of patients, addressing a major healthcare need. This was followed in 2018 by the inauguration of the third stage of the Kasr Aini Emergency Hospital 185, which included a modernized burns department and upgraded cardiac and chest care units, representing a major leap forward in the hospital's emergency infrastructure. Beyond physical infrastructure, Prof. Khodair was also involved in shaping the policies and educational partnerships of the faculty. In 2016, he publicly supported and enforced a university decision regarding a professional dress code for medical staff during working hours. He was also instrumental in fostering collaboration to enhance medical training; notably, in 2015, he signed a memorandum of understanding with the Magdi Yacoub Heart Foundation to provide Kasr El Aini doctors with specialized training in heart surgery and blood vessels. He also represented the faculty in meetings with international delegations, such as one from the Saudi health authority, to discuss quality assurance and academic programs. According to a 2023 listing, Prof. Fathy Khodair continues to practice medicine as a Consultant Plastic and Reconstructive Surgeon. His practice is currently located at the Cairo Medical Center in the Fifth Settlement, New Cairo.

Presentation Title

Radiopharmaceuticals and Precision Medicine

Abstract

How targeted imaging and therapy personalize care !!!. Radiopharmaceuticals support precision medicine by linking a biologic target to a radioactive isotope, allowing clinicians to visualize disease at the molecular level.They help identify the right patient, confirm target expression, define disease extent, and guide treatment selection.In Theranostics, the same target can be used first for diagnostic imaging and then for targeted therapy, creating a personalized care pathway.This approach improves decision-making, supports individualized dosimetry, and aims to deliver treatment more selectively to diseased tissue. Conclusion: Radiopharmaceuticals embody precision medicine by helping us see the right target, select the right patient, and, in many cases, deliver the right therapy with greater confidence.

Biography

Prof. Dr. Khalid Taalab is a Nuclear Medicine Professor at the Military Medical Academy and Nuclear Medicine Consultant at Saudi German Hospital-Egypt. He holds an M.D. in Nuclear Medicine from Cairo University (1997) and completed fellowships at London University (1995), BWZKH Koblenz Germany (2000), and St Louis University Hospital USA (2006). He served as Deputy President of the Military Medical Academy (since 2022), ESNMS General Secretariat (since 2023), and is affiliated with the Egypt Centre of Research and Regenerative Medicine (ECRRM) since August 2023. He is also an ESNMS Council and Journal Editing Board Member and co-editor of "A Concise Guide to Nuclear Medicine, 3rd Edition" (2026).

Presentation Title

Egyptian Iron Ore for Supporting National Economy - Opportunities and Challenges

Abstract

This topic aims to review and discuss the opportunities and challenges facing the optimal investment of the Egyptian iron ores. The main goal is to contribute scientifically to finding solutions and alternatives or at least to understand the problems facing the important national issue of providing suitable iron ore for steel industry, which forms the backbone of the economic development and national sustainability. Despite the widespread presence of iron ores of different types and specifications in the Egyptian desert, only the National Iron and Steel Company (1970-2020 - under liquidation) is considered a pioneering experience in the limited processing of the Egyptian iron ore, by using a specially designed blast furnace technology capable of producing steel from only the iron ore of El Gedida mine, Western Desert. The Egyptian Iron ores are of stratabound/stratiform type of near surface shallow marine and/or surficial environment, ranging in age from Early Proterozoic to Paleogene and can be chronologically categorized into: a) Pre-Cambrian Banded Iron Formation (BIF); b) Mesozoic-Tertiary oolitic (oncolitic) ironstones, and c) Oligocene (?) pre-rift iron laterite. To cooperate in discussing this problem concerning optimal industrial use of Egyptian iron ore, the following will be reviewed and discussed: a) The nature and distribution of the different Egyptian iron ore deposits and their suitability for economic mining, b) The geology, types and mode of occurrence of each ore type, c) Mineralogical composition of the different ore type, their physical characteristics and megascopic and microscopic textural parameters, d) Fe content and chemical composition of each ore type, comprising type of impurities associated with the iron ore and the nature of their presence and interaction with it, taking into account the iron concentration values and associated impurities, and their suitability for steelmaking using internationally recognized techniques (e.g. blast furnaces or electric arc furnaces EAFs, e) The geological, proven, mineable, and industrial reserves for each ore type, and f) Reviewing the results of the different ore processing and beneficiation laboratory or semi-industrial trails. We hope this will provide a scientific foundation for addressing the challenges of optimally utilizing Egyptian iron ore and localizing the steel industry. In fact, this problem represents a major scientific challenge and requires further serious scientific effort, studies and investigations to add value to the Egyptian iron ores and support the Egyptian economy. This can be achieved throw: a) Exploring new iron ore locations, b) Intensive re-evaluation of the unused and known ore sites, c) Finding modern and innovative technologies to remove impurities and increase the value of the ore economically, through beneficiation and pelletisation, and d) Developing new technological uses for the industrial application of the Egyptian iron ore deposits, according to their current specifications.

Biography

Prof. Dr. Mortada Mourad Taha El Aref is a pioneering scientific figure and one of the pillars of geology and mineral resource sciences in Egypt and the Arab world. He has dedicated more than fifty years of his life to scientific research and field application, adopting the "ascending scientific induction" methodology that brought about a fundamental transformation in understanding mineral ores and their geological evolution. His impact extended beyond the academic sphere to leave a national imprint through his leadership of the National Metallogenic Map of Egypt Project, iron exploration projects in Aswan and the Bahariya Oases, and his strategic role in international environmental management through leading the Regional Center for the Basel Convention. As the first pioneer of "Karstology" in the region, Dr. El Aref succeeded in decoding the fascinating natural landscapes of the Western Desert and Farafra Protectorates, thereby establishing a knowledge base that links ancient climate history with contemporary environmental tourism. His name remains synonymous with scientific achievement that serves sustainable development and preserves natural heritage for future generations.

Presentation Title

Nature Helps: from Lab to the Market

Abstract

Neem and Cinchona Tree Story and Parasite control Fathy A. Abdel-Ghaffar Zoology Department, Faculty of Science, Cairo university, Cairo, Egypt. Abstract This talk dealt with how plants and other Organisms Contribute to solve human and animals’ health problems. o Plagues threaten humans since their early days-nowadays with increasing importance. o Away from Viruses and Bacteria, Parasites (Eukaryotes) are one of the most dangerous agents facing human health. o Traditional or natural medicine is as old as human development of culture activities. o The effect of natural products of two plants (Neem and Cinchona trees) against Parasites is demonstrated. o Neem seeds extract (oils and Azadirachtin) is found to be effective on 10 spp. Of insects, Ticks and Mites. o Cinchona tree park and Malaria Story is discussed (Quinine, Reso chin) o History – Politics – Imperialism – Racism – Discrimination – Problem and Solution – Science and Research.

Biography

Prof. Dr. Fathy Abdel-Ghaffar is a distinguished Professor of Parasitology in the Zoology Department, Faculty of Science, at Cairo University, Egypt. A pillar of his field, his academic and research career has been dedicated to advancing the understanding of parasitology, with a significant focus on aquatic parasites, fish diseases, and the development of novel antiparasitic agents. His extensive research portfolio encompasses the morphology, taxonomy, and life cycles of various parasites, particularly those affecting economically and ecologically important fish species in Egypt. A prolific author, Professor Abdel-Ghaffar has contributed to a substantial body of scientific knowledge through numerous research papers published in reputable international journals. Beyond his research, he plays a critical role in the academic community. He has served as the Editor-in-Chief of the Journal of the Egyptian Society of Parasitology (JESP), where he guides the publication of vital research and fosters scholarly communication. As a respected educator and mentor at Cairo University, he has inspired and trained generations of students and young scientists in the intricate world of parasitology.

Presentation Title

Novel Genome Editing Approaches for a Sustainable Future

Abstract

The integration of genomic resources, AI optimization, and precise gene-editing tools is accelerating a revolution in biotechnology, transforming drug discovery, agriculture, and personalized medicine. AI acts as a "navigator," enabling the analysis of vast, multi-omics data to predict, design, and optimize gene-editing experiments, reducing trial-and-error, increasing accuracy, and minimizing off-target effects. The genome editing reemerged in 2012 with the development of CRISPR/Cas9 technology, which is a rapid, precise, and cost-effective technology. It has transformed biotechnology by enabling targeted alterations to DNA across all living organisms. This breakthrough allows for repairing mutations, enhancing agricultural resilience, and advancing medical therapies. CRISPR/Cas revolution represents a shift from earlier, less efficient methods like ZFNs and TALENs, offering unmatched, programmable gene manipulation. Novel genome editing approaches are moving beyond traditional CRISPR-Cas9 to enhance precision, reduce off-target effects, and enable larger, complex modifications without double-strand breaks (DSBs). Second-generation CRISPR-Cas–based gene editors including base editors and prime editors were developed. Key emerging technologies of third-generation novel gene editing include PASTE (Programmable Addition via Site-specific Targeting Elements), retrons (leverage retrotransposons), non-coding RNAs, epigenetic editing, transposases and recombinases.

Biography

Prof. Dr. Naglaa Abdallah is a Professor of Genetics at Faculty of Agriculture at Cairo University. She served as the coordinator of BSC Biotechnology program from 2010 to 2020. Dr. Abdallah's research expertise is on plant improvement using genome editing and plant biotechnology as well as food safety and bioinformatics. She is the Editor-in-Chief of GM Crops & Food journal. She has been named among the 100 most influential people in the field of biotechnology. She is leading the National Biotechnology Network for Expertise (NBNE), to proponent of science-based biotechnology development. She is also a member of the Institutional Biosafety Committee in the Faculty of Agriculture, Cairo University. She provides technical, societal, and ethical perspectives through her lectures and writings and on social media. She was the Director of the International Relation Office at Faculty of Agriculture, Cairo University. She published over 80 research papers in high rank journals as well as several book chapters. She was Post Doc Researcher at Ohio State University, The Scripps Research Institute and The Donald Danforth Research Center. She was a Chief of Party for a USAID project on establishing Center of Excellence of Agriculture. She was the Director of Egypt Biotechnology Information Center (EBIC). She has joined projects with ICARDA and is a consultant at ACSAD to establish Arab Biotechnology Network.

Presentation Title

Bridging the Lab-to-Market Gap: Resolving Integration Challenges in Therapeutic and Diagnostic Innovation

Abstract

The landscape of biomedical production is constantly evolving, with new research findings emerging at a higher rate. Breakthroughs in pharmaceuticals, diagnostic capacities, treatment modalities, and disease management are regularly published in medical journals. However, the transition of therapeutic and diagnostic innovations from controlled laboratory environments to large-scale industrial and clinical applications remains a significant strategic challenge. Despite rapid advancements in molecular diagnostics and biotechnology, a translational gap exists where high performing laboratory prototypes often fail to provide applicable value in the real world. This gap is frequently driven by a lack of interoperability standards, the limitations of the academic financial model, and an over- narrow focus on technical metrics. Accreditation serves as a structural solutions by providing standardized frameworks that align laboratory research with industrial requirements. For example, adopting internationally recognized proficiency testing and quality standards ensures that methodologies such as those used in genomic testing or pathogen detection are robust, reproducible, and adaptable to clinical needs. This alignment facilitates a mutual relationship: academic researchers provide innovative methodologies and an awareness of existing standards, while industry partners offer excellence in software development and the successful organization of tools. Utilizing accreditation as a foundational pillar for inverse planning allows developers to move toward clinical application rather than focusing solely on incremental gains in technical performance. This approach ensures that diagnostic and therapeutic tools are not only scientifically sound but also commercially viable and socially responsible.

Biography

With 33 years of experience as a clinical pathology specialist and molecular diagnosis expert in genetics and infectious diseases, I have contributed to the diagnosis of zoonotic diseases related to livestock, poultry, and fisheries. My work has had a significant impact on economic and public health decision-making. Throughout my career, I have established and managed various laboratories, utilizing advanced techniques such as PCR, Real-Time PCR, Capillary sequencing, and NGS sequencing. In addition to diagnostics, I have 18 years of experience in genetic testing and embryo selection at the Egyptian IVF center, as well as cancer diagnosis at Colors Medical Laboratories. This has allowed me to efficiently analyze pedigree data, identify genetic problems, calculate risk involvement, evaluate inheritance patterns, and assess disease occurrence likelihood. I have played a crucial role in identifying genetic markers for cancer detection and developing effective diagnostic strategies. I have extensive experience with technologies including hematology, bio-chemichal analysis, PCR, Real-Time PCR, gene expression, capillary sequencing, and NGS sequencing. I also have 18 years of experience in genetic testing and embryo selection using PGD. My experience includes leading the laboratory work for the AstraZeneca project in Egypt, where I supervised EGFR mutation testing in lung cancer patients, and establishing testing protocols for FGFR, KRAS, and PDL1 in bladder cancer. Additionally, I have experience with BCR-APL testing in leukemia patients. More recently, I have been focusing on One Health concepts as a consultant with the Food and Agriculture Organization regarding human –livestock interaction in bacterial resistant. For the past three years, I have been responsible for quality control procedures in cancer diagnosis and precision medicine interpretation at Colors Medical Lab. Prior to that, I worked at Horizon for scientific consultancy and the genetic lab at the Egyptian IVF-ET center. In all these positions, I consistently applied ISO17025 and 15198 guidelines to ensure accurate diagnosis results.

Presentation Title

Silicon Nanophotonics for On-Chip Integrated Circuit Technology

Abstract

Silicon nanostructures offer powerful new opportunities for compact, high-performance photonic devices. In this talk, silicon nanostructure-based optical sensors, high-confinement transmission lines, and omnidirectional mirrors are discussed. Their design principles and fabrication using a simple approach is highlighted. Design optimization strategies are discussed to enhance optical performance and integration density. Applications in photonic integrated circuits are demonstrated and compared to existing photonic technologies.

Biography

Prof. Dr. Mohamed Shaker is currently leading a research group in applied solid state physics at Cairo University, Egypt. He received his Ph. D in semiconductor physics from Kyoto University, Japan on 2007. Then, he moved to Osaka University and worked as an assistant professor at Research Center for Solar Energy Chemistry for one and half year. On 2009, he moved to Hamburg University, Germany as a postdoctoral fellow for three years. Since 2012, he returned back to Cairo University and established his research group at the department of physics. He gained good experience abroad in the field of nanoscience and nanotechnology. On 2020, he got an admistrative position as a chair of nano-manufacturing department at faculty of postgraduate studies for nanotechnology. He participated strongly in mapping out the necessary teaching materials for postgraduate students in his department and taught some nanomaterials classes. In addition, he was enjoying helping students and academic members in his department. Beside his administrative work, he was supervising his students and performing active research work in the field of nano-physics. On 2024, he quit this administrative position and joined French University in Egypt (UFE) as an adjunct professor.

Presentation Title

Space Science and Technology (SSAT): Exploration, Utilization and Commercialization

Abstract

Based on Astronomy and Space science, space technology nowadays is not just a passive provider of information, but that space activities that translated from knowledge, observation to applications for new civilization from space to Earth. As humanity embarks on a new era of sustained Space exploration, the need for a robust and precise Position, Navigation, and Timing (PNT) infrastructure becomes paramount. Space provides the infrastructure for personal mobility, communication for work or when on vacation, weather forecasting, precision farming to maximize crop harvesting and crop rotation, banking transactions, management of precious resources such as potable water, monitoring of forest fires, archaeological investigations, scientific knowledge and the dream of expanding the reach of humanity. To be on the state of arts in terms of knowledge, we will discuss the above exploration and commercial activities that rely on space science and the infrastructure to generate this data and enable its applications.

Biography

Professor of Astrophysics and Space Physics, Head of the Department. Director of the Center for Studies and Consultations of Space Science at Cairo University. The Center provides various studies and training of specialized cadres in the field of space science to contribute to the sustainable development of the university and the state.

Presentation Title

Egyptian Iron Ore as a Feedstock to the Iron and Steel Industry

Abstract

Egypt possesses substantial iron ore resources that can contribute to the sustainability and localization of raw materials for the iron and steel industry. This study assesses Egyptian iron ore as a feedstock for ironmaking, with specific focus on its applicability to blast furnace (BF) and direct reduction iron/electric arc furnace (DRI/EAF) routes. Major iron ore deposits have been already reviewed in terms of origin, mineralogy, chemical composition and physical characteristics relevant to metallurgical performance. Typical Egyptian iron ores are characterized by total iron contents ranging from approximately 48–58 wt.% Fe, with SiO₂ contents of 6–15 wt.% and Al₂O₃ contents generally below 4 wt.%, alongside variable levels of other impurities affecting process efficiency. For blast furnace operation, the relatively moderate iron grades and elevated gangue levels necessitate beneficiation and agglomeration to achieve sinter or pellet qualities compatible with stable furnace operation and acceptable slag volumes. In contrast, for DRI/EAF applications, upgrading to higher-grade concentrates and pellets with reduced silica and alumina is critical to meet the stringent requirements of gas-based direct reduction processes. The paper discusses beneficiation strategies, including crushing, grinding, and concentration, to enhance ore quality and improve its suitability for each ironmaking route. The industrial implications of utilizing domestic Egyptian iron ore are also examined, emphasizing reduced reliance on imported raw materials and improved integration of local mineral resources into the national steel value chain. The results help for finding an answer to the query of whether, with appropriate processing and quality control, Egyptian iron ore can represent a viable feedstock for both BF and DRI/EAF-based iron and steel production.

Biography

Prof. Dr. Mahmoud Ibrahim Nasr is one of the distinguished scientific figures in the fields of materials science and engineering and the iron and steel industry. He is a Professor Emeritus at the Central Metallurgical Research and Development Institute (CMRDI), where he dedicated his scientific and research career to serving the national industry and developing technologies for ore extraction and metal processing. He obtained his advanced degree in Chemical Engineering from Cairo University in collaboration with the Massachusetts Institute of Technology (MIT) in the United States, which contributed to shaping a scientific vision that combines academic depth with advanced industrial application. Prof. Dr. Mahmoud Nasr has an extensive scientific and administrative record, during which he held high leadership positions, including the presidency of the Central Metallurgical Research and Development Institute and membership on the boards of directors of major industrial and research institutions inside and outside Egypt. He has published more than ninety research papers in prestigious international journals and conferences, and participated in dozens of applied research projects to develop mining and metallurgical industries. He has received numerous awards and honors, most notably the State Encouragement Award in Engineering Sciences and the First Class Excellence Medal, in recognition of his influential scientific contributions and pioneering role in linking scientific research with sustainable industrial development.

Presentation Title

Building Precision Medicine: AI-Driven Biomarkers and Industry Integration in Emerging Healthcare Systems

Abstract

The growing complexity of immune-mediated and oncologic diseases, such as Alzheimer’s disease, multiple sclerosis, leukemia, and cancer, has highlighted the limitations of conventional diagnostic and therapeutic approaches. These conditions are driven by heterogeneous molecular and genetic mechanisms that influence disease progression, treatment response, and clinical outcomes. Consequently, there is an urgent need to shift toward precision medicine strategies based on robust molecular and genetic biomarkers. This presentation explores the identification and application of multi-omics biomarkers encompassing genomics, transcriptomics, and proteomics for improving diagnostic accuracy, prognostic stratification, and therapeutic decision-making. While substantial progress has been achieved in biomarker discovery, a critical challenge remains in translating these findings into clinically applicable tools. This gap is largely attributed to insufficient integration between academic research and biomedical manufacturing. The talk emphasizes the importance of co-developing diagnostic platforms and biomarker panels in collaboration with industry, enabling scalability, standardization, and regulatory compliance. Furthermore, it highlights the transformative role of artificial intelligence in accelerating biomarker discovery, integrating complex datasets, and optimizing predictive models for clinical use. Special attention is given to opportunities within the Egyptian healthcare system, where strong academic institutions, a large and diverse patient population, and emerging diagnostic industries provide a unique environment for advancing precision medicine. Ultimately, this work proposes an integrated framework that aligns molecular research, industrial innovation, and AI-driven analytics to facilitate the transition from discovery to implementation, improving patient outcomes and positioning regional healthcare systems at the forefront of personalized medicine.

Biography

Nashwa El-Khazragy, M.D., is a professor of clinical pathology-hematology and head of the Proteomics and Metabolomics Research Unit at the Faculty of Medicine, Ain Shams Research Institute (MASRI), Ain Shams University. She has been the managing director of Global Research Labs since 2017. Dr. El-Khazragy obtained her doctorate degree in laboratory hematology from Ain Shams University in 2010. She possesses extensive expertise in medical laboratory quality accreditation and auditing, with demonstrated experience in standards including ISO 14644-1, ISO 19011, and ISO 15189. Dr. El-Khazragy has authored over 100 research articles and served as an editor and reviewer for many peer-reviewed journals. She has supervised over 75 theses and dissertations from six Egyptian universities. Her areas of expertise include cancer biology, drug resistance, leukemia and lymphoma, molecular biomarkers, non-coding RNAs, genetics, CRISPR Cas9, CAR T cells, and gene editing.

Presentation Title

Management of the Rosy Years of Life

Abstract

Menopause is a natural biological stage in a woman’s life characterized by the permanent cessation of menstruation due to the decline of ovarian function and estrogen production. In Egypt, menopause usually occurs between the ages of 45 and 50 years, with the mean age around 48–49 years among Egyptian women. The prevalence of menopausal symptoms among Egyptian women is high, with studies reporting that about 84% of women experience one or more menopausal symptoms such as hot flushes, sleep disturbance, and mood changes. Joint pain, sleep problems, and physical or mental exhaustion are among the most commonly reported symptoms in Egyptian postmenopausal women. Additionally, genitourinary syndrome of menopause has been reported in about 89.9% of Egyptian postmenopausal women, significantly affecting quality of life and sexual functioning. Early menopause before the age of 45 occurs in approximately 1.9% of Egyptian women, and it is associated with factors such as rural residence, low education level, and reproductive history. Management of menopause in Egypt includes both medical and non-medical approaches. Hormone replacement therapy (HRT) is one of the most effective medical treatments for relieving severe vasomotor symptoms and preventing osteoporosis. However, awareness and use of HRT remain limited among Egyptian women due to concerns about side effects and lack of knowledge. Lifestyle modification is an important part of management and includes regular physical activity, balanced nutrition rich in calcium and vitamin D, and maintaining a healthy body weight. Psychological support and health education also help women cope with emotional and social changes during menopause. Herbal medicine is commonly used in Egypt as a complementary therapy for menopausal symptoms. Common herbs include fenugreek, sage, and anise, which are traditionally used to reduce hot flashes and improve hormonal balance. Some women also use phytoestrogen-containing plants such as flaxseed and soy products to relieve symptoms naturally. These herbal remedies are popular because they are affordable and culturally accepted, although scientific evidence for their effectiveness varies. Overall, effective management of menopause in Egypt requires increased awareness, access to healthcare services, and integration of medical treatment with lifestyle and complementary therapies

Biography

Prof. Dr. Osama Azmy is a Consultant to the President of the National Research Centre for medical clinical trials and Head of the Regenerative Medicine Unit at NRC. A Fellow of the Royal College of Obstetricians and Gynecologists (FRCOG), Dr. Azmy is a pioneer in regenerative medicine and reproductive health. He serves as Head of the Medical Ethics Research Committee and is a member of the Egypt Center of Research and Regenerative Medicine (ECRRM) ethics committee. His groundbreaking work in stem cell research, tissue regeneration, and reproductive medicine has positioned him as a leading expert in the field.

Presentation Title

Policies and Diplomacy of Basic Scientific Research for Societal Development: Basic Research from Laboratory to Society

Abstract

Scientific research, technology, and innovation are essential in supporting green and sustainable societies. In many countries, environmental strategies, policies, and action plans are in isolation from mainstream macroeconomic and sectoral policies, which may result in negative impacts on the environment and society. Accordingly, conventional policymaking processes do not produce the appropriate expected outcomes for achieving the Sustainable Development Goals (SDGs) and human welfare. In some regions around the world, policies, plans, and programs that do not consider environmental issues at their core have proved to have deficiencies and ineffectiveness. The main objective of this concept brief is to highlight the importance of environmental policies and diplomacy to overcome the major challenges of research and development as a tool to achieve the environmental, economic, and social objectives. This can be achieved by shifting from relying on outside technologies and know-how for developing national capacities to developing local technologies to implement the SDGs. This lecture covers the different facets of scientific research policies and diplomacy in the context of sustainable development and achieving the SDGs. Diplomacy of scientific research may overcome conflicts on sensitive issues among countries and sometimes may be the only way to initiate a wider political and diplomatic dialogue. The “soft power” of science and the universality of scientific methods succeeded in diffusing tensions of the “hard power” scenarios. The new dimensions of the international “environmental security” are currently using the “soft power” of science, particularly as security threats now extend beyond the military domain, with environmental security having considerable momentum for due attention. In conclusion, the concept of science policies and diplomacy is gaining increasing currency in different countries, however, it is still fluid, but can usefully be applied to the role of scientific research, technology and innovation in three related areas: supporting foreign policy objectives with scientific advice (science in diplomacy and development), using science cooperation to improve international relations between countries (science for diplomacy and development, and facilitating international science cooperation (diplomacy for science and development).

Biography

Prof. Dr. Ahmad Kamel Hegazy has received his PhD in Plant ecology University of Alberta, Canada during the period of 1982-1986. Currently, he is working as Professor of Applied Ecology and Conservation of Biodiversity in Cairo University. His research has included plant population and community ecology; biodiversity, conservation and management of protected areas; biological interactions; allelopathy; environmental pollution, phytoremediation, restoration ecology; and environmental impact assessment. Based on this research and fellowship training he has received several awards and honors, such as: State prize in environmental research and education (2003); State prize for encouragement in biological science (2000) and State prize for environment protection in the field of biodiversity and protected areas (1997), International publications awards- Cairo University, Silver Medal of Food and Agriculture Organization of United Nations-FAO (2002). He is serving as an editorial member/ editor-in-chief of several reputed journals like Journal of Forestry Research (Springer), Egyptian journal of botany, and some online journals & expert Reviewers for many journals published by Springer, Elsevier, Academic Press, Jon Wiley & sons, etc, beside many online journals. He has authored about 150 research articles/books. He is a member of many international, regional and national academic societies.

Presentation Title

Recombinant Technologies in Poultry Vaccine Development: From Molecular Design to Industrial Application

Abstract

The global poultry industry faces continuous challenges from emerging and re-emerging viral pathogens, necessitating rapid, scalable, and precise vaccine development strategies. Advances in recombinant DNA technologies and genetic engineering have transformed the landscape of vaccinology, enabling the rational design of safer, more effective, and highly targeted vaccines. This presentation explores the integration of molecular virology with recombinant platforms, including reverse genetics systems, viral vector engineering, and subunit vaccine design, for the development of next-generation poultry vaccines. Emphasis will be placed on strategies for antigen optimization, attenuation, and DIVA-compatible vaccine design to enhance disease control and surveillance. In addition, the talk will highlight the translation of these technologies from laboratory-scale innovation to industrial vaccine manufacturing, addressing key challenges such as genetic stability, yield optimization, and regulatory considerations. Case studies involving economically significant poultry viruses will be presented to demonstrate practical applications and impact. By bridging fundamental virology with applied biotechnology, this work underscores how recombinant approaches can accelerate vaccine development pipelines and improve preparedness against evolving viral threats.

Biography

Prof. Reda Elsayed Salem is a Professor of Molecular Virology and Head of the Molecular Biology Department at the Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center, Egypt. He also serves as a Scientific Consultant at Vaccine Valley Company, contributing to the development and industrial application of advanced vaccine technologies. Prof. Salem received his Ph.D. in Genetics from Ain Shams University, where his research focused on molecular characterization and recombinant expression of viral proteins for diagnostic and immunological applications. His work spans molecular virology, recombinant protein expression, antibody engineering, and biotechnology-driven vaccine and diagnostic development. With over two decades of research experience, he has led and participated in multiple national and international projects, including the development of recombinant diagnostic tools and antibody-based platforms for viral diseases such as Foot-and-Mouth Disease Virus (FMDV) and SARS-CoV-2. His research has contributed to innovative approaches in recombinant antibody production, subunit vaccine development, and plant-based expression systems. Prof. Salem has extensive international research experience, having conducted scientific visits and collaborative work in Italy, Germany, Poland, and the Czech Republic, focusing on recombinant protein production, monoclonal antibody generation, and plant-based vaccine technologies. He is the author of numerous peer-reviewed publications in high-impact journals in recombinant diagnostics and vaccine-related technologies. His current interests focus on integrating recombinant DNA technologies, reverse genetics, and molecular diagnostics into scalable vaccine manufacturing platforms for veterinary and zoonotic diseases.

Presentation Title

When Pharmacometrics meets AI: Shaping the future of therapeutics

Abstract

Pharmacometrics is a quantitative scientific discipline that applies mathematical and statistical modeling to describe, understand, and predict the relationships between drug dose, drug exposure, therapeutic response, and toxicity in individuals and populations. It integrates data from preclinical studies, clinical trials, and real-world evidence to support rational drug development, dose optimization, and individualized therapy. Recent advances in artificial intelligence (AI) and machine learning have significantly transformed the field of pharmacometrics. AI techniques enhance the ability to analyze large, complex, and heterogeneous datasets, uncover nonlinear relationships, and improve prediction accuracy beyond traditional model-based approaches. When combined with mechanistic pharmacometric models, AI enables more precise prediction of drug efficacy, safety, and inter-individual variability, thereby accelerating drug development and supporting personalized medicine. The integration of pharmacometrics and AI represents a powerful framework for data-driven decision-making, enabling more efficient clinical trial design, optimized dosing strategies, and improved patient outcomes.

Biography

Prof. Ebtehal El-Demerdash has over 100 peer-reviewed articles in the field of Medical sciences (Pharmacology & toxicology) published in international ISI-ranked journals since 2000. Her research focuses on exploring new drugs and investigating the mechanisms underlying their effects. Prof. El-Demerdash has won a number of scientific awards and certificates of merit. Most importantly, in 2010 she won the Encouragement State Prize in Medicine. in 2011, she was honored as Northern Region winner of the African Union Kwame Nkrumah Science Prize. In 2018, she won a grant from Science & Technology Development Fund (STDF) to establish the first Center of Excellency for Preclinical & Translational Research at faculty of Pharmacy, Ain Shams University. In 2019, she won the Ain Shams University Appreciation Award in Medical field. And in 2024 she won the State Award for Excellence in Medical Field.

Presentation Title

Current Status and Future Prospects of Medical Biotechnology in Egypt: Lessons from Monoclonal and IgY Antibodies

Abstract

Medical biotechnology is one of the most important areas of medical care in the modern world, owing to the fact that it has led to the development of new technologies in the areas of diagnosis, vaccine development, and therapy. In Egypt, there are indications of the development of medical biotechnology in the country in the past few decades, particularly in the areas of research, capacity building, and the increasing interest in the country’s biopharmaceutical industry. In this regard, the current state and future prospects of medical biotechnology in Egypt will be discussed, focusing on the case of (monoclonal antibodies) mAbs and chicken egg yolk immunoglobulins (IgY) as examples. The talk will highlight and integrate the results of the speaker's previously published research in the field of monoclonal antibodies and IgY antibodies, with regard to the potential for application in the field of infectious diseases, immune diseases, and prophylactic use. Monoclonal antibodies are the state-of-the-art technology of the recombinant biotechnological approach in Egypt, which is a model of success for the progress made in target discovery, antibody engineering, and preclinical development. IgY antibodies, on the other hand, provide a cheap and acceptable way to do passive antibody based immunotherapy, with a focus on Egypt's public health requirements. Despite the success made, there are still challenges, such as the absence of infrastructure for large-scale production, regulatory and technology transfer issues, and the need to develop the academic and industry sectors. In this talk, the speaker will elaborate on how the lessons learned from his research can be used to inform national strategies. This research, which derives lessons from the mAb and IgY technologies, offers a roadmap for how Egypt can leverage its strengths to become a prominent hub for the innovation of medical biotechnology in the region.

Biography

Prof. Dr. Ashraf Tabll is a leading figure in medical biotechnology and immunology in Egypt, internationally recognized for his pioneering work on monoclonal antibodies and IgY antibody platforms for diagnostics and immunotherapy. With more than 110 high-impact international publications, his research bridges fundamental science and real-world medical applications. He has held prestigious research appointments in the USA (Yale University, University of Connecticut Health Center) and Germany through DAAD- and STDF-funded fellowships.

Presentation Title

Basic Sciences As the Foundation of Innovation: Some Success Stories for Disease Treatment and Advanced Biomedical Applications (From Lab to Society)

Abstract

Basic sciences answer “why”, applied research delivers “how”, and innovation needs both. The talk would introduce this fact in details followed by describing some success stories from our research group that started from basic science towards disease treatment and advanced biomedical applications (From basic science labs to society) with a focus on smart nanomaterials. These smart nanomaterials represent a very favorable class of materials that are able to dramatically change their properties in response to specific environmental stimuli such as pH, temperature, magnetic field, light, electricity, certain chemicals, etc. Recently, the ability to manage the size in the nanoscale, shape, porosity and surface morphology of materials has created new opportunities to evade various challenges in various applications. Besides, the concurrent fast and considerable stimuli-response of these nano-structured smart nanomaterials may magnify the scope of their applications, and suggest improved performance in their uses especially in the biomedical fields. The talk will give an overview of the recent advances of smart nanomaterials, and will describe the in-vitro and in-vivo evaluation of several new series of our newly-developed smart nano and nano-in-micro systems for treatment and early diagnosis of different diseases.

Biography

Prof. Dr. Ibrahim M. El-Sherbiny is a tenured Professor of Nanotechnology and Nanomedicine and President of the University of Science and Technology at Zewail City, where he also serves as Founding Chairman of Nano and Materials Sciences Programs and Founding Director of the Center of Materials Science. He earned his BSc (Hons) and MSc from Mansoura University and his PhD in smart drug delivery from Massey University, New Zealand, followed by postdoctoral and research faculty appointments at the University of New Mexico and the University of Texas at Austin. With an H-index of 49 and ~10,000 citations, he has published over 280 peer-reviewed papers, authored/edited five books, contributed to 30+ books, and holds more than 25 patents. His research focuses on smart nano- and nano-in-micro systems for targeted and controlled drug delivery, tissue engineering, regenerative medicine, and biosensing. Dr. El-Sherbiny has delivered over 100 keynote and invited lectures worldwide, received more than 70 national and international awards—including the Order of the Egyptian Republic in Science and Arts—and serves as Editor of Drug Development and Industrial Pharmacy alongside multiple editorial board roles.

Presentation Title

Economic Utilization of Shale in Desert Land Reclamation and Cement Industry

Abstract

Shale (mudrocks) is used in different purposes (e.g., land reclamation and cement industry). This article discusses quality assessment of these clay materials to be more eco-friendly to environment. The study discusses the proper using of mudrocks as amandement [amendment] to improve the quality of the sandy desert lands and rocky soil profiles in the Western Desert Oases lowlands. Several integrated tests are essential to evaluate the mudrocks and soil profile efficiency before and after soil treatments; of these tests are texture & mineralogical analyses as well as pH, CEC, SP, NPK, WP and biochemical tests for plants tissues. On the other side, cement clinker manufacturing, which is considered environmentally polluted industry, depends greatly upon physico-chemical characteristics and quality of raw materials (e.g. limestone and shale), additives and alternatives. Using suitable shale make cement production more eco-friendly. Several integrated mitigation measures should be carried out to avoid environmental pollution and to reduce environmental limitation of the arid desert land and water resources.

Biography

Prof. Dr. Mohamed Ibrahim El-Anbawy, Professor of Environmental Geology, has dedicated a lifetime rich with contributions to scientific research, field applications, and service to the nation. Throughout his distinguished academic career, Prof. El-Anbawy has enriched the fields of applied geology, clay mineralogy, and environmental geology, producing over 85 published research papers and five pioneering reference books that bridge science with sustainable development. His contributions extended beyond university boundaries, bringing his expertise to construction and development sites as a consultant to numerous organizations inside and outside Egypt. He participated in more than 16 national projects for new cities (1995–2004), 10 archaeological projects, and 8 projects for evaluating sanitary landfills in cooperation with the Environmental Affairs Agency, in addition to 15 pioneering projects for environmental impact assessment. He has left distinctive marks in many interdisciplinary specializations, serving as a visiting professor in geography, archaeological restoration, prehistory, applied geology, cartography, and ancient Egyptian life. He has an influential presence through the Center for Archaeological and Environmental Engineering and the Center for Environmental Risk Reduction at Cairo University, and is the founder and vice president of the Giza Environmental Protection Association. He was internationally recognized, receiving the award for 5000 World Personalities in the American Biographical Institute book in 1986.

Presentation Title

The Role of Research and Development Centers in Promoting Active Pharmaceutical Ingredients (APIs): Achievements of the Research and Development Center for Chemical and Pharmaceutical Industries, a Pioneering Example in Egypt

Abstract

Global crises, such as the COVID-19 pandemic, geopolitical issues, and currency exchange rate fluctuations, have impacted supply chains, including those for active pharmaceutical ingredients (APIs). This crisis has prompted many countries to adopt new policies that rely on national industries to meet their needs for strategic goods, including APIs, instead of importing them. Hence, the importance and necessity of securing the national pharmaceutical industry in Egypt becomes clear through the development of clear policies with specific timeframes and performance indicators to ensure the availability of APIs by manufacturing these raw materials nationally, rather than relying on imports, as Egypt currently imports more than 95% of these raw materials. Many of the APIs can be manufactured nationally using technologies that can be developed and implemented nationally through the establishment of dedicated Egyptian research and development centers. This is because most of the methods used to prepare these raw materials are not protected by patents or any other form of commercial protection. Therefore, we established the first research and development center in this field to achieve this goal through a partnership between the National Alliances Initiative, funded by the Egypt Academy of Scientific Research and Technology, and the National Research Centre. Through our pharmaceutical research and development program, we have achieved several objectives in this area. In cooperation with all research and industrial bodies, we are striving to put the active pharmaceutical ingredient (API) industry in Egypt on the right track to secure Egypt's needs for pharmaceutical raw materials in the coming period.

Biography

Prof. Dr. Korany A. Ali is a Professor of Applied Chemistry at the National Research Centre (NRC), where he leads the Advanced Materials and Nanotechnology Group. He currently serves as Director of the R&D Centre for Chemical and Pharmaceutical Industries and Executive Director of NRC Technology Incubators. With extensive experience bridging academia and industry, Dr. Korany has held key leadership roles, including Head of the Technology Transfer Office and General Coordinator of the National Knowledge Alliance for Pharmaceutical Industries. He has participated in multiple international collaborations and visiting research positions in Europe. His research focuses on medicinal chemistry, heterocyclic synthesis, biomaterials, and nanotechnology, with over 75 international publications.

Presentation Title

Photo-assisted electrocatalysis: An effective tool for green chemical conversion

Abstract

The augmented consumption and depletion of natural resources of conventional fuel are alerting and urge the pursuit for alternative energy resources. The pollution developed from fossil fuel result in polluting both air and aquatic systems. In this respect development of new sensing approaches to mitigate pollution and effective catalysts for chemical conversion is crucial. One of the main targets is to combine the synthesis of new materials and innovation in experimental design aiming at specific chemical conversion processes. Photo-assisted electrocatalysis (PEC) is recently introduced as an innovative interdisciplinary research. PEC benefits from energies derived from light sources and electricity using specifically tailored catalysts. The special catalyst is used as a modifier over conventional electrode surfaces in an electrolytic cell or electrolyzer. The catalyst is assumed to be photo-sensitive and exceptionally electrochemically active. In this respect both thermodynamic and kinetic limitations are surpassed when addressing specific chemical conversion processes. Briefing of the concept of photo-assisted electrocatalysis will be presented. Some results will be also presented in monitoring polluted water and water-splitting for hydrogen generation.

Biography

Prof. Dr. Ahmed Galal Helmy is a Professor at the Faculty of Science, Cairo University, holding degrees from Cairo University (B.Sc., M.Sc., Ph.D.) and the University of Cincinnati, USA (M.Sc. and Ph.D.). He has held academic positions from demonstrator to full professor and has been a visiting professor at numerous international universities in the USA, Germany, UK, France, Taiwan, and Lebanon. He co-founded a distinguished scientific school in conducting polymers and advanced nanomaterials for energy and biomedical applications. He has co-authored over 240 research papers indexed in Scopus and Science Citation Index, and written 81 book chapters. Ranked among the top 2% of scientists worldwide by Stanford University and among the top 10 Arab researchers in advanced materials by the Organisation of Islamic Cooperation. He is a member of the American Chemical Society, the Electrochemical Society, and the Royal Society of Chemistry (UK), and serves on Elsevier editorial boards. He has served as Vice President of the Academy of Scientific Research, founding member of the Nano-Technology Center at Cairo University, and advisor to the Minister of Higher Education and Scientific Research.

Presentation Title

The Impact of Misleading Concepts in Science on the Faculty of Science-Cairo University Efforts to Control Schistosomiasis and Cancer. A Hope Remains: Arachidonic Acid

Abstract

Vaccination of experimental rodents and non-human primates with radiation-attenuated cercariae of Schistosoma mansoni and S. haematobium led to a consistent and highly significant reduction of 40 to 80% in challenge infection. The umbrella of the World Health Organization and Eminent Scientists helped, during the nineties of the last decade, in implementing the concept that reducing the recovery of challenge schistosomes in immunized hosts to 40% (recently pushed up to 70%) would be instrumental in controlling schistosomiasis, because the helminth pathogens, unlike viruses and bacteria, do not replicate in the final, notably human host. Irradiated cercariae should, however, be replaced by protective subunit helminth antigens, preferably in a recombinant form that is safe and easy to express and distribute. Fifty years after obtaining my Ph.D. in tumor immunobiology from the Czech Republic, I was surprised to find that cancer treatment still predominantly depends on surgery and radiotherapy, while breakthroughs involve chemotherapy and immunotherapy. Cancer growth and metastasis are essentially due to biological and immune evasion resulting from drastic changes and remodeling of the surface of the cell. Since the integrity of the surface of the cell is impaired, then the structure and function of every molecule, receptor, ion channel, and subsequent signaling to the cell interior and nucleus are impaired. Accordingly, several models and strategies of chemotherapy as well as immunotherapy could well represent nothing but hoaxes. Schistosome and cancer, notably its hallmark metastatic cells, are blood-dwelling. They are protected and shielded by the surface membrane's elevated content of sphingomyelin, and that is increasingly recognized as associated with every human cancer type. Sphingomyelin, however, could be degraded via activation of surface membrane-associated sphingomyelinases using the conditionally essential nutrient, arachidonic acid.

Biography

Prof. Rashika El Ridi is a distinguished Professor of Immunology in the Zoology Department, Faculty of Science, Cairo University, Egypt. She has been a leading figure in immunobiology research for several decades, with particular expertise in immunology and vaccine development for schistosomiasis. Prof. El Ridi earned her PhD in Immunobiology in 1975 from the Institute of Molecular Genetics, Czech Academy of Science in Prague, and later obtained her Doctor of Science (DSc) in Immunobiology from Cairo University in 2004. She began her academic career as a Lecturer in Immunology at Cairo University in 1976, was promoted to Associate Professor in 1981, and has served as Professor since 1986. In addition to her academic role, she directed Schistosomiasis Research at the Biomedical Research Center of the Egyptian Organization for Sera and Vaccines from 1990 to 2000, and was a Visiting Scientist at the Harvard School of Public Health in 1995. Her scientific contributions are widely recognized, with numerous international publications indexed in PubMed. Prof. El Ridi has received several prestigious honors, including the Egyptian State Award of Merit in High Technology Sciences (2010), the L’Oréal-UNESCO Award for Women in Science (2010), the Egyptian State Award of Excellence in High Technology Sciences (2002), and the Cairo University Award for Recognition in Applied Sciences (2002). She is fluent in Arabic, English, and French.

Presentation Title

Practical Aspects of Experimental Design in Laboratory Animal Science

Abstract

Experimental design is obviously a critical component of the success of any research project. Scientists risk drawing incorrect results and pursuing research directions that waste a lot of time and money if all components of experimental design are not carefully considered. Therefore, in order to produce reliable, repeatable results, it is essential to plan scientifically sound experiments and conduct them in accordance with accepted laboratory procedures. Data generated by this approach should be of sufficient quality for publication in well-respected peer-reviewed journals, the major form of widespread communication and archiving experimental data in research. This article provides a brief overview of the steps involved in the design of animal experiments and some practical information that should also be considered during this process.

Biography

Prof. Dr. Sohair Ramadan Fahmy is the Dean of the Faculty of Science at Cairo University and serves as the General Coordinator of the Sustainability Office. She is a distinguished Professor of Physiology in the Zoology Department, Faculty of Science, Cairo University. Born in Giza, Egypt in 1972, Prof. Fahmy earned her M.Sc. (2001) and Ph.D. (2006) degrees in Comparative Physiology from the Department of Zoology, Faculty of Science, Cairo University. Her academic career has been marked by exceptional contributions to the fields of physiology, alternative medicine, and laboratory animal science. With over 1,800 citations and an h-index of 22, Prof. Fahmy has published 85 research papers in prestigious international journals. Her research focuses on molecular and integrative physiology, comparative physiology, and alternative medicine approaches to health and disease. Prof. Fahmy is a pioneer in establishing ethical standards for animal research in Egypt. She initiated and served as the first Chairperson of the Institutional Animal Care and Use Committee (IACUC) at Cairo University's Faculty of Science, setting a precedent for responsible and ethical animal research practices in Egyptian academic institutions. Her leadership extends beyond research, as she has played a crucial role in advancing international collaborations and elevating the scientific profile of the Faculty of Science, Cairo University.

Presentation Title

Biomimetic Scaffolds and the Human Amniotic Membrane

Abstract

The human amniotic membrane (hAM) is bilayer membrane that provides nourishment and protection to the growing embryo. Historically, the hAM was used for skin and corneal repair, but over the past decades, advances in biotechnology expanded its applications due to its unique biological properties. The hAM is easy to obtain and manipulate and stimulates minimal immune responses; it exhibits anti-microbial and anti-inflammatory properties and is rich in extracellular matrix. These properties supported its use in regenerative medicine and tissue engineering applications. Our research showed that the hAM promoted the regenerative capacities of mesenchymal stem cells and somatic cells and enhanced the mitochondrial bioenergetics of adipose stem cells. We developed the hAM as a 3-D biomimetic scaffold to engineer hepatocellular carcinoma cancer organoids for applications in precision medicine. We showed that the hAM enhanced chemotherapeutic drug potency by suppressing tumor angiogenesis in a neuroblastoma cell line. We used the hAM scaffold in different formulations, as cryopreserved and lyophilized, solubilized powder, suspension based, and in micro and nanoformulations. The expanding use of the hAM in tissue engineering position it as one of the most promising candidates scaffolds for wound healing and regenerative medicine applications.

Biography

Dr. Nagwa El-Badri is the Founding Chair of the Biomedical Sciences Program and the Director of the Center of Excellence for Stem Cells and Regenerative Medicine at Zewail City of Science and Technology. Dr. Nagwa received her medical degree with honors from Cairo University College of Medicine and her Ph.D. degree with distinction from the College of Medicine, University of South Florida (USF), USA. Her postdoctoral training as a Fellow of the American Heart Association was in the field of stem cell biology. She was awarded an Initial Investigatorship Award from the American Heart Association and received research support from the Science and Technology Development Fund, the Academy of Scientific Research and Technology, the American Heart Association, the National Institutes of Health, and several other foundations. She contributed more than 100 publications and books in the field of stem cell biology and regenerative medicine. She was named Top Scholar in the stem cell field by ScholarGPS. Prior to joining Zewail City, Dr. Nagwa El-Badri was the founder and director of the Undergraduate and Graduate Program of Women’s Health at USF. She also established the graduate program in Aging and Neuroscience and the Medicine and Gender Scholarly Concentration at the College of Medicine, USF. At Zewail City, she was awarded a prestigious grant from the Science and Technology Development Fund to establish the Center of Excellence for Stem Cells and Regenerative Medicine (CESC) at Zewail City. The CESC was recently selected to receive a second large prestigious award for successful STDF-funded centers of excellence. She developed several undergraduate and graduate programs both at Zewail City and USF. Her graduate students at both institutes received many national and international awards, and several publications were awarded first place and gold medals in national and international conferences. She received numerous awards for her efforts in research and in promoting women in science. She is the recipient of the Women Appreciation Award from the Egyptian Academy of Scientific Research and Technology for 2020 and the Research Excellence Award from Zewail City in 2024. She was selected for AAMC Mid-Career Women Faculty Professional Development, USA, and was awarded Exemplary Leader in Management Position for Global Women in STEM, Meera Kaul Foundation. She is an elected Fellow of the African Academy of Sciences and the American College of Nutrition and served on several national and international committees, including the Arab League Education and Cultural Organization Research Committee, the Higher Education Reform Experts Committee, and the Council for Education and Scientific Research Policies at the Academy of Scientific Research, and the National Council for Women.

Presentation Title

Transfer, localization, and reproduction of biotechnology in Egypt

Abstract

In an effort to advance Egypt's sustainable development goals, this talk examines the strategy for transferring, localizing, and reproducing biotechnology domestically, drawing on the pioneering experiences of BRICS countries as a forward-looking model. The analysis explores Egypt's current scientific landscape, highlighting limited successes in areas such as stem cell research and the Egyptian Genome project, alongside ambitious initiatives like manufacturing protein-based drugs, all set against structural challenges including inadequate funding and a low number of patents. Economically, it underscores the substantial revenue gap between Egypt's pharmaceutical industry ($1.6 billion) and the tens of billions generated by BRICS nations, arguing that localizing the bio-industry is crucial for achieving health and food security and creating employment. The presentation also addresses the social dimension, emphasizing the need for public awareness and updated regulatory and bioethical frameworks. It concludes that biotechnology transfer is not merely a scientific pursuit but an imperative for meeting sustainable development targets related to health, food, and industry, and for building a competitive, knowledge-based economy.

Biography

Prof. Dr. Refaat Gabre is the Head of Biotechnology Department at Faculty of Science, Cairo University, specializing in Medical Entomology with a focus on insects that impact human and animal health. His research extensively explores the role of insects as vectors for diseases, including studies on ticks transmitting parasites like Babesia and bacteria such as Borrelia burgdorferi, as well as the role of sarcosaprophagous flies in spreading human pathogens like E. coli and Cryptosporidium. He has also investigated parasite contamination on fresh vegetables and conducted demographic life-table analyses of medically important fly species like Chrysomya megacephala to inform population control measures. His highly cited work, including publications on tick-borne pathogens and fly demographics, underscores his significant contributions to understanding and mitigating vector-borne diseases in Egypt and the region.

Presentation Title

Phage Innovation: Targeted Solutions for Regional Antimicrobial Challenges

Abstract

The global rise of multidrug-resistant (MDR) pathogens represents a critical challenge to modern medicine and public health. Phage therapy utilizes lytic phages to selectively target and eliminate pathogenic bacteria while preserving beneficial microbiota. The Center for Microbiology and Phage Therapy (CMP) at Zewail City focuses on the clinical and industrial applications of bacteriophages to combat AMR across the food, veterinary, and human sectors.

Biography

Prof. Ayman El-Shibiny is a Professor of Biomedical Sciences and the Director of the Center for Microbiology and Phage Therapy (CMP). He earned his Ph.D. in Microbiology from the University of Nottingham, UK, in 2006. Before joining Zewail City, Dr. El-Shibiny held several postdoctoral fellowships at prestigious institutions, including the University of Nottingham (UK), Cardiff University (UK), and The Evergreen State College (USA). As an expert microbiologist, his research addresses a broad range of topics critical to food safety and human health.

Presentation Title

Integrative Bio-Nanotechnologies for Industrial Symbiosis: Scaling the Circular Bioeconomy in Egypt

Abstract

Egypt produces approximately 30 to 35 million tons of agricultural waste annually, with only a fraction currently valorized into high-value assets. This lecture explores the transition from a linear "extract-use-dispose" model to a circular bioeconomy using a "cascading biomass" approach. By integrating plant biotechnology with nanotechnology—specifically using silver nanoparticles (AgNPs) as metabolic elicitors—researchers can optimize the production of secondary metabolites and bio-based materials from organic residues.

Biography

Prof. em. Tarek Y. S. Kapiel is currently serving as the Rapporteur of the Committee on Arts, Social Sciences, Scientific Culture, Strategic Studies, Science and Technology Indicators at the Office of Technical Evaluation, Follow-up, and Performance Evaluation of the President of ASRT in Egypt. He holds the position of Emeritus Professor in Plant Biotechnology at the Faculty of Science, Cairo University, Giza, Egypt.

Presentation Title

Computer-Aided Drug Design: From Code to Cure

Abstract

Computer-Aided Drug Design (CADD) has revolutionized modern drug discovery by transforming the traditionally slow, expensive, and high-failure-rate process of developing new medicines into a more rational, efficient, and data-driven approach. By integrating principles from computational chemistry, molecular modeling, bioinformatics, and artificial intelligence, CADD enables researchers to virtually screen, design, and optimize potential drug candidates in silico, significantly reducing the need for costly laboratory synthesis and biological testing in the early stages. This review examines the evolution of CADD from classical structure-based drug design (SBDD) and ligand-based drug design (LBDD) methodologies including molecular docking, molecular dynamics simulations, quantitative structure-activity relationship (QSAR) modeling, and pharmacophore approaches to the cutting-edge advancements in AI-driven drug design (AIDD). Breakthroughs such as AlphaFold for accurate protein structure prediction, generative AI models for de novo molecule generation, and machine learning algorithms for ADMET property prediction have dramatically accelerated hit identification, lead optimization, and the targeting of previously undruggable proteins. Despite persistent challenges related to prediction accuracy, data quality, and regulatory acceptance, CADD continues to demonstrate substantial value through successful drug repurpose efforts and contributions to clinical candidates. Ultimately, the journey from code to cure illustrates how computational innovation is reshaping pharmaceutical research, offering the potential for faster development of safer, more effective, and personalized therapeutics.

Biography

Dr. Ahmed Fikry El-Sayed is a specialist in molecular genetics and bioinformatics. He holds a Ph.D. in Molecular Genetics from Al-Azhar University and works as an Assistant Professor at King Salman International University. His expertise includes genetic variant analysis, GWAS, pharmacogenomics, and computational drug discovery. He has over 70 peer-reviewed publications in high-impact journals.

Presentation Title

Scientific Principles and Medical Applications of Artificial Intelligence

Abstract

Artificial Intelligence (AI) is founded on rigorous scientific principles from mathematics, statistics, optimization, and computational modeling. It provides computational methods that enable machines to learn from data, recognize patterns, and support complex decision-making. By transforming large-scale biomedical data into clinically meaningful insights, AI serves not only as a technological tool but also as a scientific engine for innovation in medicine. Recent advances in machine learning and deep learning have accelerated its integration into healthcare. This lecture provides a focused overview of the principles of AI and explores how AI systems support physicians in medical imaging, early disease detection, and predictive healthcare.

Biography

Dr. Areeg S. Abdalla is an Associate Professor in the Mathematics Department at the Faculty of Science, Cairo University, where she is actively involved in teaching, research, and supervision of students at undergraduate and graduate levels. Dr. Abdalla’s research spans areas in mathematical logic, artificial intelligence, machine learning, fuzzy systems, and computational intelligence, where she has authored and co‑authored numerous peer‑reviewed publications. Her work includes contributions to satisfiability problems, fuzzy classification methods, and applications of intelligent systems in data analysis and pattern recognition. In her academic role, she combines foundational mathematics with contemporary computational techniques, preparing students to tackle complex problems in both theoretical and applied contexts. Dr. Abdalla is recognized for her contributions to research communities, evidenced by citations of her work and collaborations with international scholars.

Presentation Title

Computational Transformation in Drug Discovery: Bioinformatics and AI Innovations in Pharmaceutical Science

Abstract

The pharmaceutical landscape is undergoing a profound revolution driven by the convergence of computational biology, aAI, and big data analytics. This talk explores how bioinformatics approaches and AI-powered methodologies are fundamentally reshaping the drug discovery pipeline, from target identification and lead optimization to clinical trial design and precision medicine.We will demonstrate how machine learning models and deep neural networks trained on genomic, proteomic, and clinical datasets are dramatically accelerating hit-to-lead timelines while reducing costs and attrition rates. Special attention will be given to landmark case studies where computational approaches have translated into tangible therapeutic outcomes, as well as the challenges of model interpretability and data quality.These case studies will be jointly presented with recent applications, along with the growing importance of model interpretability, multi-modal data integration, and deep learning-based fusion approaches in translating computational predictions into clinical outcomes.This talk is intended for researchers, clinicians, and industry professionals at the intersection of data science and pharmaceutical innovation.

Biography

Dr. Hamed is an associate professor of biomedical informatics and computational biology at the German university of Cairo (GUC). He is also heading the Integrative OMICs Analysis group at Rostock University Medical Center, Rostock, Germany, and was leading the computational biology activities in cancer immunology and immune modulation in one of the leading pharma industries in Europe. He is the director of the German-Egyptian university progress projects EG-CompBio and GED-PerMedAI, which aim at empowering the bioinformatics and computational biology research in the MENA region. Dr. Hamed coordinates the German Arab Research Network for Computational Life Science (GARN-CLS) between German and Arabic institutions in the region. Dr. Hamed specializes in bioinformatics and computational biology, with a strong focus on applying artificial intelligence (AI) and advanced computational methods to the analysis of genomic data. His expertise spans both academic research and industry settings, enabling translating theoretical methodologies into practical, scalable solutions in discovery research. Dr Hamed has extensive experience designing and implementing data-driven pipelines for large-scale genomic and multi-omics datasets, integrating machine learning and statistical modeling techniques to extract meaningful biological insights. A key highlight of his career has been his tenure as Principal Scientist at Boehringer Ingelheim AG, within the Global Computational Biology and Digital Sciences department (gCBDS). There, He contributed to cutting-edge translational research programs in cancer immunology and immune modulation, applying integrative analytics and machine learning pipelines to drive drug discovery initiatives.

Presentation Title

Metabolic Mastery: Engineering the PETase-MHETase Synergistic Consortium for a Truly Circular Plastic Economy

Abstract

Polyethylene terephthalate (PET) is one of the most widely used synthetic polymers, yet less than 10% of post-consumer PET waste is effectively recycled. Mechanical recycling results in downcycling, with progressive loss of material quality and eventual landfill disposal. The 2016 discovery of Ideonella sakaiensis, a Gram-negative bacterium famous for its ability to break down and consume PET plastic as its primary source of carbon and energy, besides the discovery of its PET-degrading enzymes (PETase and MHETase), offered a biological route for PET depolymerization; however, wild-type enzymes suffer from slow kinetics, poor thermostability, and product inhibition, precluding industrial application. This study aimed to develop an integrated bioprocess leveraging engineered enzymes and a synthetic microbial consortium to achieve complete, scalable, and economically viable PET recycling to virgin-grade monomers. Usage of directed evolution and machine learning-guided rational design to generate a thermostable PETase variant (FAST-PETase 2.0) with optimal activity at 65°C and >100-fold enhanced catalytic efficiency relative to the wild-type enzyme. An MHETase variant was similarly engineered for enhanced turnover of the intermediate mono(2-hydroxyethyl) terephthalic acid (MHET). To overcome the bottleneck of MHET accumulation, a synthetic consortium was constructed using Pseudomonas putida KT2440 as a host: one strain engineered to secrete FAST-PETase 2.0, and a second strain engineered for surface display of the optimized MHETase. This consortium was deployed in a 10,000 L stirred-tank bioreactor with continuous in-situ product recovery (ISPR) via membrane filtration. Post-consumer PET waste (15 kg batches, including coloured bottles and contaminated packaging) was processed at 60°C with a solids loading of 15-20%. Recovered terephthalic acid (TPA) and ethylene glycol (EG) were purified by crystallization and distillation, and then were re-polymerized to produce new PET bottles. Process performance was evaluated by depolymerization yield, monomer purity, and product quality metrics (intrinsic viscosity, colour, and mechanical strength). Life cycle assessment (LCA) was performed to quantify environmental and economic impacts. The engineered PETase-MHETase consortium achieved >98% depolymerization of post-consumer PET waste within 48 hours, representing a >10-fold reduction in processing time compared to wild-type systems. Continuous ISPR kept the product from being inhibited, which made it possible to load a lot of solids and run the reactor properly. The TPA and EG that were recovered were more than 99.8% pure. Re-polymerization produced virgin-grade PET with an intrinsic viscosity of 0.81 dL/g and a mechanical strength of 56 MPa. This is the same as virgin PET made from oil, and superior to mechanically recycled material. LCA showed that this process used 42% less energy and 55% less carbon than making virgin PET. We have established a scalable, economically viable bioprocess for the complete biological recycling of PET to virgin-grade material. The synergistic consortium approach overcomes the fundamental bottleneck of MHET accumulation that limits single-strain systems. This platform enables true circularity for PET, achieving infinite recycling without quality loss, and is extensible to other plastics, including polyurethanes and polyamides. Our findings demonstrate that engineered microbial consortia, integrated with advanced bioprocess design, can form the foundation of a sustainable, circular plastic economy.

Biography

Mohamed Abd El Gawad is an Associate Professor and Ex-Head of the Department of Microbiology and Immunology at the Faculty of Pharmaceutical Sciences and Drug Manufacturing at Misr University for Science and Technology (MUST) in Giza, Egypt. He was appointed to this position in September 2021, after having served as a lecturer in the same department since 2015. Before this, he had three years of research experience at the Faculty of Medicine, Aix-Marseille University in Marseille, France (2013-2015). In 2018, he travelled to China to pursue two years of research experience at the Zhongshan School of Medicine, Sun Yat-sen University in Guangzhou. Mohamed holds a master’s and a PhD in Microbiology and Immunology from the Faculty of Pharmacy at Cairo University (Excellent with honour). His research interests include bacteriology, epidemiology, bacterial resistance, molecular genetics, and gene mutations. He has been teaching various courses since 2006, including General Microbiology and Immunology, Parasitology, Pharmaceutical Microbiology, Medical Microbiology, Biotechnology, and Pathology. He has also supervised master's and PhD students in their research. His publications have been featured in several international journals of high impact factors, such as Emerging Infectious Diseases, mSphere, Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, International Journal of Nanomedicine, BMC Genomics, International Journal of Medical Microbiology, Emerging Microbes & Infections, Gut Pathogens, Foodborne Pathogens and Disease, Infection and Drug Resistance, and Lancet Microbe.

Presentation Title

From Lab to Market: How Science Drives Innovation in Nutrition and Food Technology

Abstract

Innovation in food and nutrition is increasingly driven by the integration of rigorous scientific principles with practical industry applications. The understanding of how analytical science forms the backbone of innovation in nutrition and food technology, enabling the development of safe, high-quality, and nutritionally optimized products. By leveraging techniques such as food composition analysis, contaminant detection, and shelf-life optimization, scientists and industry professionals can transform research findings into market-ready solutions that address both consumer needs and regulatory requirements. In Egypt, the highlighting of the opportunities and challenges in a high-demand food system characterized by rapid population growth, rising health awareness, and increasing regulatory pressure is very essential. Key gaps, including limited translation of research into commercial products and technology bottlenecks need to be discussed alongside actionable strategies for innovation, through practical examples, including functional food development and quality control optimization to demonstrate how science-driven approaches create value for both industry and society. Universities play a critical role in bridging research and application, serving as hubs for applied research, skilled workforce development, and industry collaboration. Science is not an optional component of innovation — it is its foundation.

Biography

Prof. Abdel-Rahman B. Abdel-Ghaffar is a Professor of Biochemistry at the Faculty of Science, Ain Shams University, Egypt. His academic and research expertise lies at the intersection of molecular immunology, cancer biology, and advanced therapeutic approaches. His research focuses on exploring the molecular mechanisms underlying immune responses and developing innovative strategies for cancer treatment, particularly through the application of nanotechnology and photodynamic therapy. Through his work, he aims to bridge fundamental biochemical research with translational medical applications. Prof. Abdel-Ghaffar has contributed to several peer-reviewed scientific publications and has been actively involved in academic teaching, mentoring undergraduate and postgraduate students in the fields of biochemistry and molecular biology. Beyond academia, he is the founder of the “AbdoScience” platform, where he shares simplified scientific content and supports students and young researchers in navigating their academic and research journeys. He is also engaged in scientific communication and academic event organization, contributing to the promotion of science education and research culture.

Presentation Title

AI in Biotechnology

Abstract

In this session, he will explore how AI is transforming biotechnology, from drug discovery and genomics to bioinformatics, and share insights from the development of Bio agent, highlighting the role of AI-powered tools in shaping the future of biological research and deep-tech innovation.

Biography

Mostafa Nasser is an entrepreneur, mechanical engineer, and ecosystem builder dedicated to advancing innovation at the intersection of technology and entrepreneurship. He currently serves as the Chapter Director of Startup Grind , where he leads initiatives that empower students and early-stage founders to transform ideas into scalable startups. Mostafa has been actively involved in building startup communities across Egypt, working with international innovation networks and organizing programs that connect founders with investors, mentors, and global opportunities. He has also participated in multiple international entrepreneurship programs and startup ecosystem events. With a strong interest in AI, biotechnology, and deep-tech innovation, Mostafa is currently working on Bio agent, a project focused on leveraging artificial intelligence to accelerate biotechnology research and enable smarter biological data analysis.

Presentation Title

Detection of Low Contrast, Low Resistivity Pay (lclr) Challenge in Shaly Sand Gas Reservoir Through Acoustic Data in the on Shore Nile Delta, Egypt

Abstract

The Upper Messinian Abu Madi Clastic reservoirs in the gas fields of the Nile Delta, Egypt, present challenges due to their unconventional nature, including low-resistivity reservoirs and thin-bedded intervals. The high resistivity values of gas reservoir intervals are masked by shale conductivity, leading to their neglect during conventional petrophysical evaluation. The objective is to identify these hidden reservoirs, caused by the presence of shale content, which is crucial for effective reservoir characterization and exploration in the region. The study utilized conventional triple combo logging, including the dipole sonic tool, to gather data from the wells. Log analysis and X-plots were employed to identify lithology, hydrocarbon content, and clay minerals. Petrophysical evaluation determined clay volume, porosity, water saturation, and net pay. Acoustic data, specifically compressional and shear waves, were used to create an X-plot correlating VP/VS and compressional slowness. This confirmed the presence of hidden pay zones. The approach integrated logs, inverted seismic data, and empirical velocity relationships to predict lithology and hydrocarbon content. X-plot analysis revealed relationships between rock properties and fluid content in the reservoir. This relationship was based on the absence of shear wave propagation through fluids. The petrophysical evaluation revealed that the lithology of the reservoir consisted of intercalated shale and sandstone with varying distributions of clay minerals. This variation in clay mineral types caused the actual high resistivity values to be masked, leading to incorrect interpretations and the loss of valuable net pay reservoir thickness. The low resistivity pay intervals exhibited maximum deep resistivity readings of 2.58 ohm in the pay sand reservoir and up to 1.6 ohm in the wet sand reservoir. Additionally, high readings of Vclay and Sw (water saturation) and low readings of Phi.e (effective porosity) within a very narrow range further contributed to misinterpretations. However, by applying a rock physics technique to well X1, a significant relationship was established between reservoir rock properties and the type of fluid content in the Abu Madi reservoir. Through the integration of conventional logs and acoustic data, these hidden pay reservoir intervals could be identified, overcoming the impact of clay content. A production test demonstrated the presence of gas at a rate of 5.6 MMscfd, with a choke size of 46/64" and a well head pressure of 2960 psi. These successful results provide encouragement for the application of this technique in detecting gas-bearing reservoirs in similar previously undetected zones. The introduced method enables the optimization of reserves and production by identifying previously overlooked reservoir intervals and adding a new thickness of net pay. This was verified through well testing, which demonstrated the presence of hydrocarbons in these low resistivity reservoir intervals, along with low water cut values.

Presentation Title

From Molecules to Taste: The Role of Organic Chemistry in Flavor Manufacturing and Food Innovation

Abstract

Flavor is one of the most important factors influencing consumer acceptance of food products. Behind every familiar taste and aroma lies a complex mixture of organic molecules that interact to create the sensory experience we recognize as flavor. Modern flavor manufacturing relies heavily on principles of organic chemistry, analytical chemistry, and sensory science to design, reproduce, and stabilize these aroma compounds in different food systems. The talk will explore how fundamental concepts of organic chemistry underpin the development and manufacturing of flavor systems used in modern food products. It will highlight key classes of aroma compounds—such as esters, aldehydes, terpenes, and lactones—and explains how their molecular structures and chemical reactivity influence flavor perception, stability, and performance in different food matrices. More importantly, the presentation will focus on the critical role of academic research in solving real industrial problems. Examples will illustrate how analytical techniques, reaction mechanism studies, encapsulation technologies, and stability investigations can help address issues such as flavor degradation, color fading in beverages, and loss of aroma during processing and storage. By demonstrating the connection between laboratory research and industrial application, this talk aims to emphasize the importance of stronger collaboration between universities and the food industry.

Biography

Mohamed Anwar Abdelwahab is an experienced food industry professional with over 17 years in Research and Development. He currently serves as R&D Manager at Techno Taste Company (Flavor House), where he leads flavor formulation, product innovation, and quality development initiatives. His career spans roles at British American Tobacco Egypt, Compass Egypt, and Al Mokhtabar Laboratories. He holds an MBA from Cairo University (GPA 3.95), is currently pursuing a DBA, and has a background in analytical biochemistry and food science. His expertise bridges applied organic chemistry, flavor science, and industrial problem-solving.

Presentation Title

Achieving Quality and Sustainable Local Vaccine Production in Africa to Improve Access

Abstract

Key Highlights of the Session: The Enablers: Exploring technological advancements, strategic collaborations, strong manufacturing capacities, and regulatory support driving the industry. The Barriers: Addressing critical challenges such as high R&D costs, complex regulatory processes, supply chain issues, and intellectual property rights. The Way Forward: Actionable strategies to overcome these obstacles and ensure that safe, effective vaccines are available to people worldwide.

Biography

Dr. Abdelfattah Kamal With over 24 years of leadership in the pharmaceutical and biopharmaceutical sectors, Dr. Abdel Fatah currently serves as the Operations Director at BioGeneric pharma (BGP). He specializes in transforming complex scientific research into scalable, commercial realities, successfully spearheading the readiness of new bio-similar and sterile vial filling lines. His professional mission is to build self-sustaining, cGMP-compliant manufacturing hubs that bridge the gap between innovation and patient access in emerging markets. An expert in startup environments, he excels at implementing Lean and Six Sigma practices, reducing production costs, and integrating automation while maintaining the highest quality standards.

Presentation Title

Advanced Vaccine Bioprocessing: From Strain Selection to Market Release

Abstract

Driven by the strategic imperative to localize vaccine manufacturing in Low- and Middle-Income Countries (LMICs), this session bridges the gap between industrial ambition and technical execution. We provide a comprehensive roadmap of the bioprocessing lifecycle, dissecting critical Upstream and Downstream operations across Bacterial, Viral, and mRNA platforms. By focusing on process optimization, scale-up challenges, and advanced purification strategies, this presentation aims to equip the workforce with the practical expertise required to secure national health resilience and independent pandemic preparedness.

Biography

Dr. Ahmed Youssef is a Production Deputy Manager and Vaccine Line Head at BioGeneric Pharma (BGP), where he leads the technical operations and drives compliance with global GMP and ISO standards. A PhD candidate in Microbiology at Al-Azhar University he focuses on the global challenge of Antimicrobial Resistance (AMR). Dr. Youssef played a pivotal role in launching BGP’s sterile production lines, achieving full regulatory compliance and operational excellence. He contributed to BGP’s selection as a recipient of Africa’s mRNA vaccine platform and led critical technology transfers for essential vaccines and biological products. His expertise in Aseptic Process Simulations (Media Fills) spans both single-use systems and conventional sterile lines, ensuring robust sterility assurance across platforms. Prior to BGP, Dr. Youssef served as Production Section Head and Supervisor at VACSERA, gaining foundational experience in biopharmaceutical manufacturing and quality systems. He was selected as one of the five inaugural Africa CDC Biomanufacturing Fellows (a program designed to prepare and equip future leaders in Africa’s biomanufacturing field) and currently serves as an Instructor in Manufacturing Science & Technology (MSAT) and Technical Operations, appointed by the Africa CDC Director General. Dr. Youssef is an active member of the American Society for Microbiology (ASM) and remains deeply committed to Africa CDC’s vision of achieving 60% locally manufactured vaccines on the continent by 2040.

Presentation Title

Borehole Images from Pixels to Insights

Abstract

In recent years, SLB has revolutionized subsurface understanding with a new generation of cutting edge logging while drilling technologies. These tools move beyond conventional measurements, delivering core like geological insight while drilling continues uninterrupted. What once required costly, time consuming coring operations can now be visualized in real time, transforming each drilled foot into a high value geological data source. With advanced imaging and high resolution petrophysical sensors, these tools reveal reservoir architecture with exceptional clarity—capturing sedimentary features, fractures, bedding patterns, and subtle textural variations that are critical for accurate interpretation. This immediate visibility empowers geologists and drilling teams to refine models, adjust trajectories, and identify key reservoir intervals with far greater confidence. The real breakthrough comes from integrating these measurements with AI driven workflows. Machine learning enhances interpretation by automatically recognizing patterns, highlighting geological trends, and reducing uncertainty. The result is faster, smarter, and more consistent decision making across the entire drilling and reservoir evaluation process. As the energy industry evolves toward efficiency and sustainability, such innovations play a pivotal role. By combining high quality LWD data with advanced analytics, SLB is opening a new frontier of subsurface intelligence—where geology becomes clearer, decisions sharper, and the path to optimal reservoir development more certain than ever.

Biography

Dr. Sahar Hassan is a Senior Geologist and Sedimentologist specializing in Digital Subsurface Solutions at SLB. She brings more than 17 years of experience in reservoir characterization, sedimentology, and borehole image interpretation across the MENA region and several international basins, including Egypt, Syria, Jordan, Iraq, Qatar, Yemen, Mexico, Pakistan, and Indonesia. Dr. Hassan earned her Ph.D. in Sedimentology (2023) and M.Sc. in Geology (2019) from Cairo University. Her academic and professional career has centered on understanding sedimentary processes, reservoir architecture, and stratigraphic frameworks, integrating core descriptions, bio stratigraphic data, and petrophysical evaluation to build high resolution subsurface models. In her current role at SLB, she focuses on advancing AI and machine learning driven workflows for geological interpretation and reservoir characterization. Her work bridges traditional geoscience with digital innovation—leveraging automation, pattern recognition, and advanced analytics to deliver more predictive, efficient, and data driven subsurface insights. Dr. Hassan is recognized for her ability to transform complex geological data into actionable technical solutions. Her multidisciplinary expertise and forward looking approach make her a sought after speaker and contributor to global discussions on the future of digital geoscience.